Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.50
Bid: 53.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.887%)
Open: 53.50
High: 53.50
Low: 53.50
Prev. Close: 53.50
FEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Harwood Capital LLP

10 Feb 2020 14:00

RNS Number : 5210C
Harwood Capital LLP
10 February 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Harwood Capital LLP on behalf of funds and private clients managed and/or advised by Harwood Capital LLP.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

North Atlantic Smaller Companies Investment Trust Plc ("NASCIT") for which Harwood Capital LLP acts as investment adviser.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Frenkel Topping Group Plc ("Frenkel Topping")

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

7 February 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of 0.5p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

-

-

-

-

(2) Cash-settled derivatives:

 

-

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

-

-

-

-

 

TOTAL:

-

-

-

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Harwood Capital LLP acts as investment adviser to NASCIT, a UK investment trust listed on the Main Market of the London Stock Exchange.

 

Christopher Mills is a director and the majority shareholder, alongside his sons, of Harwood Capital Management Limited, which is a designated corporate member and the controller of Harwood Capital LLP. Mr Mills, as Chief Executive of NASCIT, has control of investment decisions in relation to NASCIT's investment portfolio subject to oversight by the board of NASCIT.

 

NASCIT is interested in 15,100,000 ordinary shares of 0.5p each in Frenkel Topping, representing approximately 19.99% of the total voting rights.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

10 February 2020

Contact name:

James Agnew

Telephone number:

020 7640 3200

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEURVORRAUUAAR
Date   Source Headline
15th Sep 20165:26 pmRNSDirector/PDMR Shareholding
26th Aug 20163:21 pmRNSHolding(s) in Company
26th Aug 20163:15 pmRNSDirector/PDMR Shareholding
26th Aug 20168:32 amRNSHolding(s) in Company
23rd Aug 20167:00 amRNSExercise of Options
23rd Aug 20167:00 amRNSExercise of Options
23rd Aug 20167:00 amRNSExercise of Options and Total Voting Rights
16th Aug 20167:00 amRNSTrading Update
3rd Aug 20167:00 amRNSDirector/PDMR Shareholding
11th Jul 20167:00 amRNSHalf-year Report
22nd Jun 20167:00 amRNSNotice of Results
16th Jun 20162:02 pmRNSDirector/PDMR Shareholding
16th Jun 20167:00 amRNSDirectorate Change
14th Jun 20162:10 pmRNSHolding(s) in Company
14th Jun 20162:10 pmRNSHolding(s) in Company
18th May 201610:38 amRNSResult of AGM
18th May 20167:00 amRNSAGM Statement
5th May 20163:46 pmRNSDirector Dealing
26th Apr 20168:21 amRNSChange of Adviser
6th Apr 20163:16 pmRNSDirector/PDMR Shareholding
1st Apr 20163:48 pmRNSDirector/PDMR Shareholding
31st Mar 201610:06 amRNSDirector/PDMR Shareholding
24th Mar 201611:48 amRNSDirector/PDMR Shareholding
14th Mar 201610:28 amRNSFCA Permissions Received
14th Mar 20167:00 amRNSFinal Results
26th Jan 20169:05 amRNSCorrection: Trading and strategy update
25th Jan 20167:00 amRNSTrading and strategy update and notice of results
11th Nov 20158:53 amRNSHolding(s) in Company
6th Oct 20159:52 amRNSExercise of Options
9th Sep 20154:44 pmRNSHolding(s) in Company - Replacement
8th Sep 20153:52 pmRNSHolding(s) in Company
7th Sep 20155:57 pmRNSHolding(s) in Company
1st Sep 20157:03 amRNSAcquisition and Board Appointment
18th Aug 20152:25 pmRNSDirector/PDMR Shareholding
13th Jul 20154:41 pmRNSInterim Dividend Timetable
13th Jul 20157:00 amRNSInterim Results
19th May 201510:44 amRNSResult of AGM
19th May 20157:00 amRNSAGM Statement
23rd Mar 20157:00 amRNSFinal Results
10th Feb 20157:00 amRNSHolding(s) in Company
6th Feb 201510:05 amRNSHolding(s) in Company
19th Jan 20157:00 amRNSTrading Update and Notice of Results
16th Dec 20143:16 pmRNSHolding(s) in Company
15th Dec 20143:02 pmRNSDirector/PDMR Shareholding
21st Nov 20149:48 amRNSDirector/PDMR Shareholding
21st Jul 20147:00 amRNSInterim Results
23rd Jun 201411:18 amRNSHolding(s) in Company
2nd Jun 20144:04 pmRNSDirector/PDMR Shareholding
29th May 20149:28 amRNSExercise of Options
14th May 201410:45 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.